Who is sponsoring NCT05480813?

NCT05480813 is sponsored by DEO NV.

What drugs are being tested in NCT05480813?

Interventions in NCT05480813: Automated KINCISE™ impaction system versus handheld traditional mallet, Efficiency and ergonomics analysis and physical assessments.

What condition does NCT05480813 study?

NCT05480813 studies Total Hip Arthroplasty (THA).

Is NCT05480813 still recruiting?

NCT05480813 is currently completed. Last updated 29 July 2022.

Last reviewed 2022-07-29 · How we verify

NCT05480813: KINCISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Automated and Manual Component Impaction in Total Hip Arthroplasty

Completed NA Last updated 29 July 2022

What this trial tests

NA trial testing Automated KINCISE™ impaction system versus handheld traditional mallet in Total Hip Arthroplasty (THA) in 1 participant. Completed in 19 July 2022.

Timeline

14 July 2022

Primary endpoint
19 July 2022

19 July 2022

Quick facts

Lead sponsor	DEO NV
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	1
Start date	14 July 2022
Primary completion	19 July 2022
Estimated completion	19 July 2022
Sites	1 location across Belgium

Drugs / interventions tested

Automated KINCISE™ impaction system versus handheld traditional mallet
Efficiency and ergonomics analysis and physical assessments

Conditions studied

Total Hip Arthroplasty (THA) — all drugs for Total Hip Arthroplasty (THA) →

Sponsor

DEO NV

Who can join

Eligibility, male only, with Total Hip Arthroplasty (THA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate and evaluate the ergonomic impaction and the operational efficiency of the KINCISE™ impaction system in comparison with the manual impaction of a handheld traditional mallet in total hip arthroplasty (THA) procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Total Hip Arthroplasty (THA)

Currently open trials in the same condition.

NCT07392515 — Cognitive and Physical Recovery After Hip Fracture in Frail Patients Using Digital Rehabilitation Technology · NA · recruiting
NCT07427758 — Effect of Cognitive Behavioral Therapy on Kinesiophobia and Functional Outcomes After Total Hip Arthroplasty. · NA · recruiting
NCT06883591 — Triaxial Accelerometry Study · active not recruiting
NCT07453498 — Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty · NA · recruiting
NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05480813 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DEO NV
Last refreshed: 29 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05480813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing